{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-26-000009","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.056169+00:00","generated_at":"2026-05-15T23:30:59.145210+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics reports record 2025 revenue $236.3M (+15% YoY); Q4 first positive free cash flow $9.8M","bullets":["Record FY2025 revenue $236.3M, up 15% from $204.7M in 2024.","Q4 2025 revenue $61.6M (+17% YoY); net loss per share $0.43 vs $0.69.","Adjusted EBITDA FY2025 $14.8M vs $8.5M; Q4 adjusted EBITDA $4.8M vs $3.0M.","Generated $9.8M free cash flow in Q4, first positive FCF quarter; cash $62.9M.","FY2026 guidance: revenue $262-266M (11-13% growth), adjusted EBITDA ~$25M, breakeven cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-26-000009","json":"https://secwatch.observer/filing/0001425450-26-000009.json","markdown":"https://secwatch.observer/filing/0001425450-26-000009.md","text":"https://secwatch.observer/filing/0001425450-26-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/0001425450-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000009/kids-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:30:59.145210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}